Study used blood test to identify distinct molecular signatures of disease; paves the way to precision medicine for cystic fibrosis
Researchers at Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago, and colleagues, used a blood test and microarray technology to identify distinct molecular signatures in children with cystic fibrosis. These patterns of gene expression ultimately could help predict disease severity and treatment response, and lead to therapies tailored to each patient’s precise biology. Findings were published in Physiological Genomics.
“Our findings pave the way to precision medicine for cystic fibrosis patients, eventually helping us match treatment to each patient’s unique genomic pattern of disease,” says lead author Hara Levy, MD, MMSc, from Manne Research Institute at Lurie Children’s, who is an Associate Professor of Pediatrics at Northwestern University Feinberg School of Medicine. “Our study was the first to identify molecular signatures of cystic fibrosis from a blood test taken during a routine clinic visit, giving us a baseline. Greater understanding of these molecular signatures may lead to unique molecular markers that could help us intervene earlier to changes in a patient’s inflammatory response to airway infection or pancreatic function, allowing us to provide more focused treatment. It would be a huge improvement over the one-size-fits-all treatment approach we currently have for patients with cystic fibrosis.”
To identify baseline molecular signatures in cystic fibrosis, Dr. Levy’s lab obtained genomic information from patients’ blood samples using cutting-edge technologies such as Affymetric array and Illumina MiSeq. The team then merged this genomic information with each individual’s clinical history gathered from electronic medical records. They compared this snapshot of patient-specific data with healthy controls. Their study provides strong evidence for distinct molecular signatures in cystic fibrosis patients that correlate with clinical outcomes.
Cystic fibrosis is a progressive genetic disease that damages multiple organs, including the lungs and pancreas. Currently, the average predicted survival is 47 years. Although cystic fibrosis is caused by dysfunction of a single gene (CFTR) and treatment that targets CFTR mutations is available, the relationships between the abnormal gene product, development of inflammation and disease progression are not fully understood. This limits the ability to predict a patient’s clinical course, provide individualized treatment and rapidly monitor treatment response.
For example, it is not clear why patients with cystic fibrosis are susceptible to chronic lung infections, since they are considered to have a functional immune system.
“We are now trying to discover why patients with cystic fibrosis become infected so easily,” says Dr. Levy. “We are taking a closer look at the immune cells that make up many of the molecular signatures we found in cystic fibrosis.”
More study is needed before precision medicine for cystic fibrosis reaches the clinic.
“With more research, a blood test to gather genomic specifics of each patient’s disease might be available in the clinic within the next five years,” says Dr. Levy. “Precision medicine will revolutionize care for cystic fibrosis patients.”
The Latest on: Cystic fibrosis
via Google News
The Latest on: Cystic fibrosis
- Ivy's fight for Orkambi drug to treat Cystic Fibrosis on February 19, 2019 at 7:51 am
A mother and daughter from Portsmouth are asking people to take part in a challenge to raise awareness of Cystic Fibrosis. Five-year-old Ivy Weir has the condition and her mother Gemma has started a p... […]
- Directors of cystic fibrosis drug firm in NHS standoff made £15m on February 19, 2019 at 4:54 am
Vertex’s headquarters in Boston, Massachusetts. Photograph: Brian Snyder/Reuters Two UK directors of Vertex Pharmaceuticals, the company in a stand-off with the NHS over the high price of its breakthr... […]
- Merrylands family rally to raise awareness and funds for cystic fibrosis on February 18, 2019 at 7:00 pm
We had never heard of cystic fibrosis 4½ years ago, yet it’s a genetic condition that my husband and I had unknowingly passed on to our little boy. Simon was diagnosed with cystic fibrosis at the age ... […]
- Row over cystic fibrosis drug that 'costs too much' on February 16, 2019 at 4:12 pm
Campaigners have warned that a row between the government and a US drug supplier could affect the life expectancy of thousands of young cystic fibrosis patients. A drug called Orkambi could help many ... […]
- Man With Cystic Fibrosis Was Ready To Die Until He Found Bodybuilding on February 16, 2019 at 3:47 pm
A man with cystic fibrosis who admitted he was ‘ready to let his disease take his life’ has defied all odds by becoming a bodybuilder. Jared Wells, 22, from Denver, Colorado, was diagnosed with the ge... […]
- Cystic fibrosis drug scandal: Here's why we need the wonder drug right now on February 16, 2019 at 5:01 am
Senna van Engelen, who receives the drug free through her country's health service, is one of hundreds of children whose lives have been transformed since Orkambi was licensed in the Netherlands in 20... […]
- Jared Wells Has Cystic Fibrosis. Bodybuilding Changed His Life. on February 15, 2019 at 10:07 am
A longer version of this story appeared on the podcast Endless Thread. Jared Wells is originally from Utica, New York. And he recently started training to become a pro bodybuilder. Right now, Jared's ... […]
- Tragic plight of aspiring makeup artist, 25, suffering from cystic fibrosis is on her third and FINAL set of lungs on February 15, 2019 at 9:20 am
Tiffany Senter is just 25, but she has already had three sets of lungs. She was born with cystic fibrosis, a chronic genetic disease that causes sticky fluid to build up in several organs, including t... […]
- Harrowing photo of terminally ill woman’s diseased lungs shows cruel reality of cystic fibrosis on February 15, 2019 at 3:43 am
Tiffany Senter was diagnosed with the condition at seven days old. She's already had two lung transplants and doctors say if this one fails there is nothing more they can do A pair of black, diseased ... […]
- Cystic fibrosis on February 14, 2019 at 7:36 am
Are you sure your patient has cystic fibrosis? What are the typical findings for this disease? Patients with cystic fibrosis can be asymptomatic at diagnosis if diagnosed through newborn screening or ... […]
via Bing News